Approaches to Cancer Therapy Using Biological Response Modifiers
- 1 May 1985
- journal article
- review article
- Published by Elsevier in Veterinary Clinics of North America: Small Animal Practice
- Vol. 15 (3) , 667-688
- https://doi.org/10.1016/s0195-5616(85)50064-9
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- Modulation of the Metastatic Activity of Melanoma Cells by Laminin and FibronectinScience, 1984
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Separation and analysis of the major forms of plasma fibronectinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983
- Plasma Perfused over Immobilized Protein A for Breast CancerNew England Journal of Medicine, 1982
- Regulation of the Immune Response by Idiotypic-Antiidiotypic InteractionsNew England Journal of Medicine, 1981
- The Born-Again SpleenNew England Journal of Medicine, 1978
- SYNTHESIS OF FIBRONECTIN BY CULTURED HUMAN ENDOTHELIAL CELLSAnnals of the New York Academy of Sciences, 1978
- IMMUNOTHERAPY OF EXPERIMENTAL CANCER AS A GUIDE TO THE TREATMENT OF HUMAN CANCERAnnals of the New York Academy of Sciences, 1976
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- SERUM-MEDIATED LEUKEMIA CELL DESTRUCTION IN AKR MICEThe Journal of Experimental Medicine, 1973